Metabolic

Latest Features

Lowering LDL Cholesterol HIV: Pitavastatin vs Pravastatin

Lowering LDL Cholesterol HIV: Pitavastatin vs Pravastatin

Pitavastatin had greater low-density lipoprotein-lowering effects than pravastatin.

Fasting vs Nonfasting Lipid Values and Cardiovascular Risk: Q&A With Advisory Board Member, Eliot Brinton, MD

Fasting vs Nonfasting Lipid Values and Cardiovascular Risk: Q&A With Advisory Board Member, Eliot Brinton, MD

Eliot Brinton, MD, FAHA, FNLA, president and director of the Utah Lipid Center, discusses the benefits of fasting lipid profiles in predicting cardiovascular risk.

New Recommendation for Glucose-Lowering Drug Clinical Trials

New Recommendation for Glucose-Lowering Drug Clinical Trials

The International Hypoglycaemia Study Group now recommends that glucose levels lower than 3.0 mmol/L (54 mg/dL) be documented in clinical trials of glucose-lowering drugs.

Understanding Obesity's Role in Atrial Fibrillation

Understanding Obesity's Role in Atrial Fibrillation

The comorbid conditions of obesity and atrial fibrillation require better prevention and treatment strategies.

Preventing Heart Failure One Risk Factor at a Time

Preventing Heart Failure One Risk Factor at a Time

Avoiding 3 major risk factors for heart failure—hypertension, diabetes, and obesity—may reduce the likelihood of heart failure development.

Physical Activity for Diabetes: ADA Updated Guidelines

Physical Activity for Diabetes: ADA Updated Guidelines

Physical activity guidelines were updated for patients with type 2 diabetes, type 1 diabetes, and prediabetes.

Hope for Heart Failure in Thyroid Hormone Therapy

Hope for Heart Failure in Thyroid Hormone Therapy

Subclinicial hypothyroidism has been associated with an increased risk for coronary heart disease events and mortality.

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

Among patients with heterozygous familial hypercholesterolemia, alirocumab was associated with a 75% reduction in lipoprotein apheresis compared with placebo.

Reducing the Progression of Coronary Heart Disease With Estradiol

Reducing the Progression of Coronary Heart Disease With Estradiol

In light of ELITE trial results, estradiol hormone therapy may have a role in coronary heart disease treatment.

Higher Vitamin D Levels May Related to Higher Total Cholesterol, HDL-C

Higher Vitamin D Levels May Related to Higher Total Cholesterol, HDL-C

Vitamin D may influence cardiovascular disease risk via its effect on lipid levels.

Latest News

Overweight/Obesity Affects Brain Function in Type 2 Diabetes

Overweight/Obesity Affects Brain Function in Type 2 Diabetes

Overweight or obese patients with type 2 diabetes mellitus are more likely to show severe and progressive brain function and cognition abnormalities.

Low HbA1c After Metformin Initiation Lowers CV Risks in T2D Patients

Low HbA1c After Metformin Initiation Lowers CV Risks in T2D Patients

A large, initial reduction in hemoglobin A1c (HbA1c) and achievement of low HbA1c levels 6 months after metformin initiation lowered the risk for cardiovascular events and death in patients with type 2 diabetes.

Severe Hypoglycemia Affects Short-Term Mortality in Type 2 Diabetes

Severe Hypoglycemia Affects Short-Term Mortality in Type 2 Diabetes

The majority of patients with diabetes requiring hospitalization for severe hypoglycemia were patients with type 2 diabetes.

Acute MI In-Hospital Mortality Rates in Type 2 Diabetes

Acute MI In-Hospital Mortality Rates in Type 2 Diabetes

Patients with type 1 diabetes admitted for acute myocardial infarction had higher mortality rates compared with patients with type 2 diabetes.

Effect of Avocados on Metabolic Syndrome Components

Effect of Avocados on Metabolic Syndrome Components

Avocado consumption most affected LDL, HDL, and total cholesterol, triglycerides, and phospholipids.

Stroke and MI Rates Have Decreased Since Trans Fatty Acid Restrictions Enacted

Stroke and MI Rates Have Decreased Since Trans Fatty Acid Restrictions Enacted

Compared with New York counties without trans fatty acid restrictions, those with restrictions showed a significantly greater decline in combined myocardial infarction and stroke events.

Lower HbA1c Post-PCI Promotes Better Outcomes in Diabetes

Lower HbA1c Post-PCI Promotes Better Outcomes in Diabetes

Patients with HbA1c levels had lower 7-year incidence of major adverse cardiac and cerebrovascular events compared with patients with higher HbA1c levels.

Glucose Levels May Affect Functional Outcomes After Endovascular Thrombectomy

Glucose Levels May Affect Functional Outcomes After Endovascular Thrombectomy

The effect of hypoglycemia on functional outcomes after endovascular thrombectomy differs, depending on collateral status.

Cardiovascular Disease Risk Increases With Body Weight Fluctuations

Cardiovascular Disease Risk Increases With Body Weight Fluctuations

Increases in body weight fluctuations were associated with greater risk for coronary and cardiovascular events and death.

Cardiometabolic Comorbidities Found in Majority of Inpatients With Schizophrenia, Bipolar Disorder

Cardiometabolic Comorbidities Found in Majority of Inpatients With Schizophrenia, Bipolar Disorder

Study results emphasize the importance of identifying optimal treatment regimens for patients with serious mental illness.

Sign Up for Free e-Newsletters